Risk of cytomegalovirus disease in high‐risk liver transplant recipients on valganciclovir prophylaxis: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Risk of cytomegalovirus disease in high‐risk liver transplant recipients on valganciclovir prophylaxis: A systematic review and meta‐analysis

Published:2012-12 Issue:12 Volume:18 Page:1440-1447
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Kalil Andre C.¹,Mindru Cezarina²,Botha Jean F.³,Grant Wendy J.³,Mercer David F.³,Olivera Marco A.²,McCartan Megan A.³,McCashland Timothy M.²,Langnas Alan N.³,Florescu Diana F.¹

Affiliation:

1. Divisions of Infectious Diseases,University of Nebraska Medical Center, Omaha, NE

2. Hepatology,University of Nebraska Medical Center, Omaha, NE

3. Transplantation Surgery, University of Nebraska Medical Center, Omaha, NE

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lt.23530

Reference25 articles.

1. Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

2. U.S. Food and Drug Administration. Dear healthcare professional letter for Valcyte (valganciclovir HCl tablets).http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm169502.htm. Published September2003. Accessed July 2012.

3. Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy

4. Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes?

5. International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detrimental impact of immunosuppressive burden on clinical course in patients with Cytomegalovirus infection after liver transplantation;Transplant Infectious Disease;2023-11-27

2. Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center;Transplant Infectious Disease;2022-06

3. Title-Inflammatory Signaling Pathways in Allergic and Infection-Associated Lung Diseases;Allergies;2022-06-01

4. Comparison of standard versus low‐dose valganciclovir regimens for cytomegalovirus prophylaxis in high‐risk liver transplant recipients;Transplant Infectious Disease;2021-08-29

5. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients;Clinics and Research in Hepatology and Gastroenterology;2020-09